The Cameroon Mobile Phone SMS (CAMPS) trial: a randomized trial of text messaging versus usual care for adherence to antiretroviral therapy

Lawrence Mbuagbaw, Lehana Thabane, Pierre Ongolo-Zogo, Richard T Lester, Edward J Mills, Marek Smieja, Lisa Dolovich, Charles Kouanfack, Lawrence Mbuagbaw, Lehana Thabane, Pierre Ongolo-Zogo, Richard T Lester, Edward J Mills, Marek Smieja, Lisa Dolovich, Charles Kouanfack

Abstract

Background: Mobile phone technology is a novel way of delivering health care and improving health outcomes. This trial investigates the use of motivational mobile phone text messages (SMS) to improve adherence to antiretroviral therapy (ART) over six months.

Methodology/principal findings: CAMPS was a single-site randomized two-arm parallel design trial in Yaoundé, Cameroon. We enrolled and randomized HIV-positive adults on ART, aged 21 years and above to receive a weekly standardized motivational text message versus usual care alone. The primary outcome was adherence measured using a visual analogue scale (VAS), number of doses missed (in the week preceding the interview) and pharmacy refill data. Outcomes were measured at 3 and 6 months. Service providers and outcome assessors were blinded to allocation. Analysis was by intention-to-treat. Between November and December 2010, 200 participants were randomized, with 101 in the intervention group and 99 in the control group. At 6 months, overall retention was 81.5%. We found no significant effect on adherence by VAS>95% (risk ratio [RR] 1.06, 95% confidence interval [CI] 0.89, 1.29; p = 0.542; reported missed doses (RR 1.01, 95% CI 0.87, 1.16; p>0.999) or number of pharmacy refills (mean difference [MD] 0.1, 95% CI: 0.23, 0.43; p = 0.617. One participant in the intervention arm reported a possible disclosure of status.

Conclusions/significance: Standardized motivational mobile phone text messages did not significantly improve adherence to ART in this study. Other types of messaging or longer term studies are recommended.

Registration: 1. Pan-African Clinical Trials Registry; PACTR201011000261458 2. Clinicaltrials.gov; NCT01247181.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1. CONSORT flow diagram for CAMPS…
Figure 1. CONSORT flow diagram for CAMPS trial.

References

    1. WHO/UNAIDS (2005) Resource needs for an expanded response to AIDS in low and middle-income countries. Available: via the Internet. Accessed 20 November 2010.
    1. Sinha SR, Barry M (2011) Health technologies and innovation in the global health arena. N Engl J Med 365: 779–782.
    1. Kaplan WA (2006) Can the ubiquitous power of mobile phones be used to improve health outcomes in developing countries? Global Health 2: 9.
    1. Lester R T, Gelmon L, Plummer FA (2006) Cellphones: tightening the communication gap in resource-limited antiretroviral programmes? AIDS 20: 2242–2244.
    1. Keutchankeu RT, Nzepa ON (2005) Towards an African e-index: ICT access and usage. Available: via the internet. Accessed 21 May 2012.
    1. Gillwald A, Milek A, Stork C. Gender Assessment of ICT access and usage in Africa. Available: via the internet. Accessed 21 May 2012.
    1. Mukund Bahadur KC, Murray PJ (2010) Cell Phone Short Messaging Service (SMS) for HIV/AIDS in South Africa: A literature review. Stud Health Technol Inform 160: 530–534.
    1. Lester RT, Ritvo P, Mills EJ, Kariri A, Karanja S, et al. (2010) Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet 376: 1838–1845.
    1. Pop-Eleches C, Thirumurthy H, Habyarimana JP, Zivin JG, Goldstein MP, et al. (2011) Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders. AIDS 25: 825–834.
    1. Horvath T, Azman H, Kennedy GE, Rutherford GW (2012) Mobile phone text messaging for promoting adherence to antiretroviral therapy in patients with HIV infection. Cochrane Database Syst Rev 3 CD009756.
    1. WHO (2003) Adherence to long-term therapies: Evidence for action. Available via the internet. (Accessed 27 May 2012).
    1. SF Tools (2010) The SF-12: An even shorter Health Survey. Available: via the Internet. Accessed 9 November 2010.
    1. Mbuagbaw L, Thabane L, Ongolo-Zogo P, Lester RT, Mills E, et al. (2011) The Cameroon mobile phone SMS (CAMPS) trial: a protocol for a randomized controlled trial of mobile phone text messaging versus usual care for improving adherence to highly active anti-retroviral therapy. Trials 12: 5.
    1. Schulz KF, Altman DG, Moher D (2010) CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med 152: 726–732.
    1. UNICEF (2010) Cameroon statistics. Available: via the Internet. Accessed 20 January 2012.
    1. WHO (2010) Patient safety: Yaounde, Cameroon-HUG, Switzerland. Available: via the Internet. Accessed 13 November 2010.
    1. Mbuagbaw L, Bonono-Momnougui RC, Thabane L (2012) Considerations in using text messages to improve adherence to highly active antiretroviral therapy: a qualitative study among clients in Yaoundé, Cameroon. HIV AIDS (Auckl) 4: 45–50.
    1. Maimen LA, Becker MH (1974) The health belief model: origins and correlates in psychological theory. Health Educ Monogr 2: 336–53.
    1. Abramson JH (2004) WINPEPI (PEPI-for-Windows): computer programs for epidemiologists. Epidemiol Perspect Innov 1: 6.
    1. Strandbygaard U, Thomsen SF, Backer V (2010) A daily SMS reminder increases adherence to asthma treatment: a three-month follow-up study. Respir Med 104: 166–171.
    1. Kouanfack C, Laurent C, Peytavin G, Mawamba Nkene Y, Essomba C, et al. (2008) Adherence to Antiretroviral Therapy Assessed by Drug Level Monitoring and Self-Report in Cameroon. J Acquir Immune Defic Syndr 48: 216–219.
    1. Little RJA, Rubin DB (1987) Statistical analysis with missing data. New York: John Wiley & Sons.
    1. Liu H, Golin CE, Miller LG, Hays RD, Beck CK, et al. (2001) A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med 134: 968–977.
    1. Martin S, Elliott-DeSorbo DK, Calabrese S, Wolters PL, Roby G, et al. (2009) A comparison of adherence assessment methods utilized in the United States: perspectives of researchers, HIV-infected children, and their caregivers. AIDS Patient Care STDS 23: 593–601.
    1. Cramer JA, Scheyer RD, Mattson RH (1990) Compliance declines between clinic visits. Arch Intern Med 150: 1509–1510.
    1. Roux P, Kouanfack C, Cohen J, Marcellin F, Boyer S, et al. (2011) Adherence to antiretroviral treatment in HIV-positive patients in the Cameroon context: promoting the use of medication reminder methods. J Acquir Immune Defic Syndr 57 Suppl 1: S40–43.
    1. Shet A, Arumugam K, Rodrigues R, Rajagopalan N, Shubha K, et al. (2010) Designing a mobile phone-based intervention to promote adherence to antiretroviral therapy in South India. AIDS Behav 14: 716–720.
    1. Boyer S, Clerc I, Bonono CR, Marcellin F, Bile PC, et al. (2011) Non-adherence to antiretroviral treatment and unplanned treatment interruption among people living with HIV/AIDS in Cameroon: Individual and healthcare supply-related factors. Soc Sci Med 72: 1383–1392.
    1. Thirumurthy H, Lester RT (2012) M-health for health behaviour change in resource-limited settings: applications to HIV care and beyond. Bull World Health Organ 90: 390–392.
    1. Hardy H, Kumar V, Doros G, Farmer E, Drainoni ML, et al. (2011) Randomized controlled trial of a personalized cellular phone reminder system to enhance adherence to antiretroviral therapy. AIDS Patient Care STDS 25: 153–161.
    1. Thompson MA, Mugavero MJ, Amico KR, Cargill VA, Chang LW, et a l (2012) Guidelines for Improving Entry Into and Retention in Care and Antiretroviral Adherence for Persons With HIV: Evidence-Based Recommendations From an International Association of Physicians in AIDS Care Panel. Ann Intern Med 156 11: 817–833.

Source: PubMed

3
Suscribir